The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Biomarkers in COVID-19: An Up-To-Date Review
Open accessAbstract
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of intensive care services, selection of appropriate therapies, monitoring and timely discharge are essential to save the maximum number of lives. Clinical assessment is indispensable, but laboratory markers, or biomarkers, can provide additional, objective information which can significantly impact these components of patient care. COVID-19 is not a localized respiratory infection but a multisystem disease caused by a diffuse systemic process involving a complex interplay of the immunological, inflammatory and coagulative cascades. The understanding of what the virus does to the body and how the body reacts to it has uncovered a gamut of potential biomarkers. This review discusses the different classes of biomarkers – immunological, inflammatory, coagulation, hematological, cardiac, biochemical and miscellaneous – in terms of their pathophysiological basis followed by the current evidence. Differences between children and adults are highlighted. The role of biomarkers in the diagnosis and management of Multisystem Inflammatory Syndrome in Children (MIS-C) is reviewed. The correlation of biomarkers with clinical and radiological features and the viral load, temporal evolution and the effect of treatment remain to be studied in detail. Which biomarker needs to be evaluated when and in whom, and how best this information can contribute to patient care are questions which currently lack convincing answers. With the evidence currently available broad guidelines on the rational use of available biomarkers are presented. Integrating clinical and laboratory data, monitoring trends rather than a single value, correlating with the natural course of the disease and tailoring guidelines to the individual patient and healthcare setting are essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Epidemiology of COVID-19 Among Children in China
Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020) · Pediatrics · doi:10.1542/peds.2020-0702 · Cited by 4,090
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Feldstein, L. R., Rose, E. B., Horwitz, S. M., Collins, J. P., Newhams, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021680 · Cited by 2,643
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Tan, L., Wang, Q., Zhang, D., Ding, J., Huang, Q., Tang, Y.-Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,690
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14859 · Cited by 1,347
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Consiglio, C. R., Cotugno, N., Sardh, F., Pou, C., Amodio, D., Rodriguez, L., Tan, Z., Zicari, S., Ruggiero, A., Pascucci, G. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.016 · Cited by 919 · cited 1×
“Although its clinical features overlap with that of Kawasaki disease, it differs from this condition with respect to T cell subsets, interleukin (IL)-17A, and biomarkers associated with arterial damage (18).”
BackgroundCOVID-19 and multisystem inflammatory syndrome in children and adolescents
Jiang, L., Tang, K., Levin, M., Irfan, O., Morris, S. K., Wilson, K., Klein, J. D., & Bhutta, Z. A. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30651-4 · Cited by 826
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study
Yao, Y., Cao, J., Wang, Q., Shi, Q., Liu, K., Luo, Z., Chen, X., Chen, S., Yu, K., Huang, Z., et al. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00466-z · Cited by 675
Association of inflammatory markers with the severity of COVID-19: A meta-analysis
Zeng, F., Huang, Y., Guo, Y., Yin, M., Chen, X., Xiao, L., & Deng, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.055 · Cited by 669
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Lippi, G., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.004 · Cited by 652
Swann, O. V., Holden, K. A., Turtle, L., Pollock, L., Fairfield, C. J., Drake, T. M., Seth, S., Egan, C., Hardwick, H. E., Halpin, S., et al. (2020) · BMJ · doi:10.1136/bmj.m3249 · Cited by 643
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
Tian, W., Jiang, W., Yao, J., Nicholson, C. J., Li, R. H., Sigurslid, H. H., Wooster, L., Rotter, J. I., Guo, X., & Malhotra, R. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26050 · Cited by 640
Lagunas‐Rangel, F. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25819 · Cited by 606
Catanzaro, M., Fagiani, F., Racchi, M., Corsini, E., Govoni, S., & Lanni, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0191-1 · Cited by 605
Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620937175 · Cited by 604
COVID-19 in 7780 pediatric patients: A systematic review
Hoang, A., Chorath, K., Moreira, A., Evans, M., Burmeister-Morton, F., Burmeister, F., Naqvi, R., Petershack, M., & Moreira, A. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100433 · Cited by 533
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
Liu, T., Zhang, J., Yang, Y., Ma, H., Li, Z., Zhang, J., Cheng, J., Zhang, X., Zhao, Y., Xia, Z., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012421 · Cited by 498
Davies, P., Evans, C., Kanthimathinathan, H. K., Lillie, J., Brierley, J., Waters, G., Johnson, M., Griffiths, B., du Pré, P., Mohammad, Z., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30215-7 · Cited by 475
Zhao, Y., Qin, L., Zhang, P., Li, K., Liang, L., Sun, J., Xu, B., Dai, Y., Li, X., Zhang, C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.139834 · Cited by 408
A systematic review and meta‐analysis of children with coronavirus disease 2019 (COVID‐19)
Cui, X., Zhao, Z., Zhang, T., Guo, W., Guo, W., Zheng, J., Zhang, J., Dong, C., Na, R., Zheng, L., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26398 · Cited by 402
Wang, D., Yin, Y., Hu, C., Liu, X., Zhang, X., Zhou, S., Jian, M., Xu, H., Prowle, J., Hu, B., et al. (2020) · Critical Care · doi:10.1186/s13054-020-02895-6 · Cited by 397
Sperotto, F., Friedman, K. G., Son, M. B. F., VanderPluym, C. J., Newburger, J. W., & Dionne, A. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-020-03766-6 · Cited by 385
Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 380
Radia, T., Williams, N., Agrawal, P., Harman, K., Weale, J., Cook, J., & Gupta, A. (2021) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.08.001 · Cited by 369
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Figliozzi, S., Masci, P. G., Ahmadi, N., Tondi, L., Koutli, E., Aimo, A., Stamatelopoulos, K., Dimopoulos, M., Caforio, A. L. P., & Georgiopoulos, G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13362 · Cited by 361
Ghahramani, S., Tabrizi, R., Lankarani, K. B., Kashani, S. M. A., Rezaei, S., Zeidi, N., Akbari, M., Heydari, S. T., Akbari, H., Nowrouzi-Sohrabi, P., et al. (2020) · European Journal of Medical Research · doi:10.1186/s40001-020-00432-3 · Cited by 355
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce, C. A., Preston-Hurlburt, P., Dai, Y., Aschner, C. B., Cheshenko, N., Galen, B., Garforth, S. J., Herrera, N. G., Jangra, R. K., Morano, N. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5487 · Cited by 353
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J., & Pickkers, P. (2020) · JAMA · doi:10.1001/jama.2020.17052 · Cited by 333
Clinical characteristics of COVID‐19 in children: A systematic review
Yasuhara, J., Kuno, T., Takagi, H., & Sumitomo, N. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24991 · Cited by 291
C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
Wang, G., Wu, C., Zhang, Q., Wu, F., Yu, B., Lv, J., Li, Y., Li, T., Zhang, S., Wu, C., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa153 · Cited by 286
Bellmann-Weiler, R., Lanser, L., Barket, R., Rangger, L., Schapfl, A., Schaber, M., Fritsche, G., Wöll, E., & Weiss, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082429 · Cited by 244
Shi, C., Wang, C., Wang, H., Yang, C., Cai, F., Zeng, F., Cheng, F., Liu, Y., Zhou, T., Deng, B., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12880 · Cited by 225
Yan, X., Li, F., Wang, X., Yan, J., Zhu, F., Tang, S., Deng, Y., Wang, H., Chen, R., Yu, Z., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26061 · Cited by 211
Aziz, M., Fatima, R., Lee-Smith, W., & Assaly, R. (2020) · Critical Care · doi:10.1186/s13054-020-02995-3 · Cited by 210
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 (June 2020)
Hanson, K. E., Caliendo, A. M., Arias, C. A., Englund, J. A., Lee, M. J., Loeb, M., Patel, R., El Alayli, A., Kalot, M. A., Falck-Ytter, Y., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa760 · Cited by 207
Fernandes, D. M., Oliveira, C. R., Guerguis, S., Eisenberg, R., Choi, J., Kim, M., Abdelhemid, A., Agha, R., Agarwal, S., Aschner, J. L., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.016 · Cited by 205
Serum ferritin as an independent risk factor for severity in COVID-19 patients
Lin, Z., Long, F., Yang, Y., Chen, X., Xu, L., & Yang, M. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.053 · Cited by 196
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis
Li, J.-W., Han, T.-W., Woodward, M., Anderson, C. S., Zhou, H., Chen, Y.-D., & Neal, B. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.008 · Cited by 193
Urra, J. M., Cabrera, C. M., Porras, L., & Ródenas, I. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108486 · Cited by 187
Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis
Soraya, G. V., & Ulhaq, Z. S. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.05.017 · Cited by 162
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
Rello, J., Storti, E., Belliato, M., & Serrano, R. (2020) · European Respiratory Journal · doi:10.1183/13993003.01028-2020 · Cited by 158
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19
Qin, J., Cheng, X., Zhou, F., Lei, F., Akolkar, G., Cai, J., Zhang, X.-J., Blet, A., Xie, J., Zhang, P., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15528 · Cited by 152
Clinical Characteristics of Children With COVID-19: A Meta-Analysis
Ding, Y., Yan, H., & Guo, W. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00431 · Cited by 149
Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19
Hou, H., Zhang, B., Huang, H., Luo, Y., Wu, S., Tang, G., Liu, W., Mao, L., Mao, L., Wang, F., et al. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13450 · Cited by 146
Xu, Z.-S., Shu, T., Kang, L., Wu, D., Zhou, X., Liao, B.-W., Sun, X.-L., Zhou, X., & Wang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0211-1 · Cited by 145
COVACTA trial raises questions about tocilizumab's benefit in COVID-19
Furlow, B. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30313-1 · Cited by 133
Kappert, K., Jahić, A., & Tauber, R. (2020) · Biomarkers · doi:10.1080/1354750x.2020.1797880 · Cited by 132
Li, Y., Hu, Y., Yu, J., & Ma, T. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0431-6 · Cited by 129
Prata‐Barbosa, A., Lima‐Setta, F., Rodrigues-Santos, G., Lanziotti, V. S., de Castro, R. E. V., de Souza, D. C., Raymundo, C. E., de Oliveira, F. R. C., de Lima, L. F. P., Tonial, C. T., et al. (2020) · Jornal de Pediatria · doi:10.1016/j.jped.2020.07.002 · Cited by 129
Pranata, R., Huang, I., Lukito, A. A., & Raharjo, S. B. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137884 · Cited by 115
Dhanalakshmi, K., Venkataraman, A., Balasubramanian, S., Madhusudan, M., Amperayani, S., Putilibai, S., Sadasivam, K., Ramachandran, B., & Ramanan, A. V. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-2025-1 · Cited by 113
Bao, C., Tao, X., Cui, W., Yi, B., Pan, T., Young, K. H., & Qian, W. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00172-4 · Cited by 111
Toraih, E. A., Elshazli, R. M., Hussein, M. H., Elgaml, A., Amin, M. N., El‐Mowafy, M., El‐Mesery, M., Ellythy, A. M., Duchesne, J. C., Killackey, M. T., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26166 · Cited by 110
Decreased T cell populations contribute to the increased severity of COVID-19
Liu, R., Wang, Y., Li, J., Han, H. W., Xia, Z., Liu, F., Wu, K., Yang, L., Liu, X., & Zhu, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.019 · Cited by 106
Zheng, Y., Zhang, Y., Chi, H., Chen, S., Peng, M., Lifei, L., Chen, L., Li, J., Shen, B., & Wang, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0377 · Cited by 105
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
Amgalan, A., & Othman, M. (2020) · Platelets · doi:10.1080/09537104.2020.1768523 · Cited by 104
COVID-19 and RAS: Unravelling an Unclear Relationship
D’Ardes, D., Boccatonda, A., Rossi, I., Guagnano, M. T., Santilli, F., Cipollone, F., & Bucci, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083003 · Cited by 99
COVID‐19 and coagulation dysfunction in adults: A systematic review and meta‐analysis
Lin, J., Yan, H., Chen, H., He, C., Lin, C., He, H., Zhang, S., Shi, S., & Lin, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26346 · Cited by 95
Ma, X., Liu, S., Chen, L., Zhuang, L., Zhang, J., & Xin, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26208 · Cited by 90
Liu, R., Ma, Q., Han, H. W., Su, H., Liu, F., Wu, K., Wang, W., & Zhu, C. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0220 · Cited by 89
Thromboinflammation in COVID-19 acute lung injury
Mitchell, W. B. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.06.004 · Cited by 86
Dove, M. L., Jaggi, P., Kelleman, M. S., Abuali, M. M., Ang, J. Y., Ballan, W. M., Basu, S. K., Campbell, M. J., Chikkabyrappa, S. M., Choueiter, N. F., et al. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.10.026 · Cited by 83
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19
Ni, M., Tian, F., Xiang, D., & Yu, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26070 · Cited by 63
Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis
Soraya, G. V., & Ulhaq, Z. S. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.05.004 · Cited by 59
COVID-19 in children: current evidence and key questions
Munro, A. P. S., & Faust, S. N. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000690 · Cited by 57
Hemostatic Abnormalities in COVID-19: An Update
Aggarwal, M., Dass, J., & Mahapatra, M. (2020) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01328-2 · Cited by 50
Deng, P., Ke, Z., Ying, B., Qiao, B., & Yuan, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.018 · Cited by 47
Alnor, A. B., Sandberg, M. B., Gils, C., & Vinholt, P. J. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa098 · Cited by 44
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions
Minno, M. N. D. D., Calcaterra, I. L., Lupoli, R., Storino, A., Spedicato, G. A., Maniscalco, M., Minno, A. D., & Ambrosino, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072244 · Cited by 43
Coagulation dysfunction is associated with severity of COVID‐19: A meta‐analysis
Zhu, J., Pang, J., Ji, P., Zhong, Z., Li, H., Li, B., Zhang, J., & Lu, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26336 · Cited by 43
COVID-19: An up-to-date review – from morphology to pathogenesis
Vaideeswar, P., Bal, A., Agrawal, R., Arava, S. K., & Jain, A. (2020) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_779_20 · Cited by 41
Yip, C. Y. C., Yap, E. S., Mel, S. D., Teo, W. Z. Y., Lee, C., Kan, S., Lee, M. C. C., Loh, W. N. H., Lim, E. L., & Lee, S. Y. (2020) · British Journal of Haematology · doi:10.1111/bjh.16847 · Cited by 39
Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019
Li, L., Zhou, Q., & Xu, J. (2020) · BioMed Research International · doi:10.1155/2020/7413673 · Cited by 35
Wu, X., Liu, L., Jiao, J., Yang, L., Zhu, B., & Li, X. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1802061 · Cited by 34
Laboratory abnormalities in children with novel Coronavirus Disease 2019
Bourkhissi, L., Fakiri, K. E., Nassih, H., Qadiry, R. E., Bourrahouat, A., Sab, I. A., Rada, N., Draïss, G., & Bouskraoui, M. (2020) · Clinical Medicine Insights Pediatrics · doi:10.1177/1179556520955177 · Cited by 34
Wahezi, D. M., Lo, M. S., Rubinstein, T. B., Ringold, S., Ardoin, S. P., Downes, K. J., Jones, K. B., Laxer, R. M., Madan, R. P., Mudano, A. S., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41455 · Cited by 33
Dosanjh, A. (2020) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0066 · Cited by 16
What are the drugs having potential against COVID-19?
Küçükoğlu, K., Faydalı, N., & Bul, D. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02625-1 · Cited by 13
Yang, J., Zhao, X., Liu, X., Sun, W., Zhou, L., Wang, Y., & Sui, H. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00368 · Cited by 12
Cited by
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients
Pietrobon, A. J., Andrejew, R., Custódio, R. W. A., Oliveira, L. D. M., Scholl, J. N., Teixeira, F. M. E., de Brito, C. A., Glaser, T., Kazmierski, J., Goffinet, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012027 · Cited by 23
Metadata
- Authors
- Samprathi, M., & Jayashree, M.
- Venue
- Frontiers in Pediatrics
- Publisher
- Frontiers Media SA
- Published
- 2021-03-30
- Volume
- 8
- Pages
- 607647-607647
- ISSN
- 2296-2360 (ISSN-L)
- OpenAlex
- W3150010507
- Cited by
- 290
- References
- 83
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.